8-K/AThe WireRoutine
Reg FD Disclosure
Filed Mar 13, 2023 · 3y ago · Accession 0001493152-23-007317
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Immix Biopharma, Inc.
- Ticker
- IMMX
- CIK
- 1873835
- Form type
- 8-K/A
- Filing date
- Mar 13, 2023
- Report date
- Mar 10, 2023
- Document
- form8-ka.htm
- Size
- 210 KB